Search

Issue
Title
Authors
Regional experience of administration of lenvatinib and pembrolizumab combination in patients with disseminated renal cell carcinoma
Kadyrova D.D., Anzhiganova Y.V., Zukov R.A.
Prognosis improvement in elderly patients with metastatic renal cell carcinoma in the era of systemic therapy and factors affecting survival rates
Semenov D.V., Orlova R.V., Shirokorad V.I., Kostritsky S.V.
Combination of lenvatinib and pembrolizumab in treatment of patients with metastatic renal cell carcinoma and factors of poor prognosis
Klimov A.V., Karyakin A.O., Drobot N.T., Gazaryan E.O., Kabardaev R.M., Valiev A.K., Matveev V.B., Averianova S.V.
A case of treatment in a patient with synchronous bilateral renal cell carcinoma and simultaneous metastatic involvement of both adrenal glands: Clinical observation
Latypov V.R., Dambaev G.T., Popov O.S., Latypova V.N.
Experience of using 1st line combination immunotherapy in patients with metastatic renal cell carcinoma
Kalpinskiy A.S., Myslevtsev I.V., Andrianov A.N., Nyushko K.M., Golovashchenko M.P., Vorobiev N.V., Chertkova Y.L., Shirukova I.K., Usanova E.Y., Alekseev B.Y.
Neoadjuvant targeted therapy in patients with renal cell carcinoma
Alekseev B.Y., Nyushko K.M., Kalpinsky A.S.
Evaluation of the efficiency of combination palliative treatment in patients with metastatic clear-cell renal cell carcinoma
Borisov P.S., Orlova R.V., Shkolnik M.I., Karlov P.A.
CURRENTLY AVAILABLE TREATMENT OPTIONS FOR METASTATIC RENAL CELL CARCINOMA
Alekseev B.Y., Kaprin A.D., Kolesnikov G.P., Mukhomed’yarova A.A., Konopleva E.I., Kalpinskiy A.S.
Real-world outcomes of lenvatinib plus pembrolizumab in intermediateand poor-risk metastatic renal cell carcinoma
Tsimafeyeu I.V., Sultanbaev A.V., Dubovichenko D.M., Murzalina M.J., Volkov A.A., Orlova R.V., Utyashev I.A., Malina G.D., Gluzman M.I.
Possibilities of optimization of the second line targeted therapy for metastatic renal cell carcinoma
Markova A.S., Matveev V.B.
Individual approach in choosing second-line targeted therapy for metastatic renal cell carcinoma
Alekseev B.Y., Shevchuk I.M., Kaprin A.D.
Potential biomarkers for nivolumab therapy of metastatic renal cell carcinoma
Sayapina M.S., Savyolov N.A., Lyubimova N.V., Timofeev Y.S., Nosov D.A.
Everolimus in patients with metastatic renal cell carcinoma previously treated with bevacizumab: a prospective multicenter study CRAD001LRU02T⃰
Tsimafeyeu I., Snegovoy A., Varlamov S., Safina S., Varlamov I., Gurina L., Manzuk L.
СLINICAL EXAMPLES OF THE EFFICACY OF BEVACIZUMAB + INTERFERON-ALPHA IN LOW DOSES IN PATIENTS WITH ADVANCED RENAL CELL CARCINOMA
Popov A.M., Karyakin O.B.
Efficacy and safety of cabozantinib in metastatic renal cell carcinoma patients: Russian multicenter observational study
Volkova M.I., Kalpinskiy A.S., Men'shikov K.V., Gorbuleva L.V., Evsyukova O.I., Meltonyan V.R., Mishugin S.V., Maturov M.R., Ol'shanskaya A.S., Shemetov D.Y., Sannikova T.A., Makhnutina M.V., Filip'eva M.A., Gaysina E.A., Ovchinnikova E.G., Matveev V.B., Alekseev B.Y.
Efficacy and safety of lenvatinib in combination with everolimus in metastatic renal cell carcinoma resistant to antiangiogenic targeted therapy: Russian multicenter observational study ROSLERCM
Volkova M.I., Abdelgafur A.M., Aivazov M.T., Amoev Z.V., Babina K.G., Borisov P.S., Vorontsovа A.A., Evstigneeva I.V., Evsyukova O.I., Zhelezin O.V., Kalpinsky A.S., Karabina E.V., Kirdakova N.V., Kolesnikov G.P., Kuzmina E.S., Latipova D.K., Leonenkov R.V., Maturov M.R., Meskikh A.V., Mishugin S.V., Ovchinnikova E.G., Olshanskaya A.S., Protsenko S.A., Semiglazova T.Y., Smirnov R.V., Usynin E.A., Fael M.M., Cherniakova E.M., Shumskaya I.E.
Lenvatinib in combination with everolimus in metastatic renal cell carcinoma resistant to antiangiogenic targeted therapy: an initial Russian experience
Volkova M.I., Evsyukova O.I., Olshanskaya A.S., Matveev V.B.
Targeted therapy in patients with poor-prognosis renal cell carcinoma
Alekseev B.Y., Kalpinskiy A.S., Mukhomed’yarova A.A., Nyushko K.M., Kaprin A.D.
Cytoreductive nephrectomy and its effect on prognosis in patients with disseminated renal cell carcinoma receiving treatment in wide clinical practice
Semenov D.V., Orlova R.V., Shirokorad V.I., Kostritskiy S.V., Gluzman M.I., Korneva Y.S.
Metastatic renal cell carcinoma kidney in children 10 years old – possibility of targeted therapy
Pavlov A.Y., Sabirzyanova Z.R., Zheludkova O.G., Mikhalchenko A.V.
Sorafenib is the first targeted agent to treat metastatic kidney cancer
Matveev V.B., Chernyaev V.A.
EFFICIENCY OF USING A COMBINATION OF AVASTIN AND LOW-DOSE INTERFERON-Α2A IN THE TREATMENT OF METASTATIC RENAL CELL CARCINOMA
Alekseev B.Y., Kalpinsky A.S.
USE OF TARGET DRUGS IN A HETEROGENEOUS POPULATION OF PATIENTS WITH METASTATIC KIDNEY CANCER
Alekseev B.Y., Kalpinskiy A.S.
PROGNOSTIC VALUE OF VHL GENE ALTERATION IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA
Nosov D.A., Yakovleva E.S., Fedyanin M.Y., Chekini D.A., Sinitsyna M.N., Savelov N.A., Mikhailenko D.S., Zaletayev D.V., Lyubchenko L.N., Tjulandin S.A.
Practical recommendations for the prevention and correction of adverse reactions of sunitinib
Gutorov S.L., Borisova E.I.
Five-year overall survival of metastatic renal cell carcinoma patients treated with everolimus after progression on bevacizumab: a prospective multicenter study CRAD001LRU02T
Safina S.Z., Varlamov S.A., Snegovoy A.V., Varlamov I.S., Gurina L.I., Manzuk L.V., Tsimafeyeu I.V.
Optimization of sequential targeted therapy
Alekseev B.Y., Kalpinskiy A.S., Nyushko K.M., Taraki I.A., Kaprin A.D.
Axitinib in the successive targeted therapy of patients with metastatic kidney cancer
Alekseev B.Y., Kalpinsky A.S., Nyushko K.M., Kaprin A.D.
First experience of using Pembroria® medication in patients with disseminated renal cell carcinoma
Shevchuk I.M., Movchan N.D.
New lenvatinib and pembrolizumab combination for metastatic renal cell carcinoma in 1st line drug treatment: comparative effectiveness and safety
Alekseev B.Y., Shevchuk I.M.
A new alternating regimen in metastatic renal cell carcinoma presented through a clinical case
Sayapina M.S., Shiryaev S.V., Krylov A.S., Ryzhkov A.D., Titov D.A., Nosov D.A.
Metastasectomy in patients with multiple and oligometastases of renal cell carcinoma treated in general clinical practice
Semenov D.V., Orlova R.V., Shirokorad V.I., Kostritskiy S.V., Karlova N.A.
Solitary kidney cancer metastasis in the thoracic spine: case report
Zamyatnin S.A., Gonchar I.S.
Efficacy of incomplete metastasectomy in combination with targeted therapy in metastatic kidney cancer patients
Borisov P.S., Orlova R.V., Shkolnik M.I., Karlov P.A., Topuzov E.E.
SEQUENTIAL USE OF TARGET AGENTS AND THEIR COMBINATION IN THE TREATMENT FOR METASTATIC RENAL CELL CARCINOMA
Alekseyev B.Y., Kalpinsky A.S.
1 - 35 of 35 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"